share_log

Is 2023 The 'Trickle Down Year' For NOV? Why This Wall Street Analyst Is Bullish

Is 2023 The 'Trickle Down Year' For NOV? Why This Wall Street Analyst Is Bullish

2023年是11月的“涓滴年”嗎?為什麼這位華爾街分析師看漲
Benzinga Real-time News ·  2022/09/30 13:22

Bank Of America analyst Chase Mulvehill upgraded NOV (NYSE:NOV) from Neutral to Buy with a price target of $19.

美國銀行分析師蔡斯·穆爾韋希爾已升級十一月(紐約證券交易所股票代碼:11月)從中性到買入,目標價為19美元。

Key Takeaways: As NOV crushed earnings in the first half of 2022, management has guided the second half of 2022 adjusted EBITDA of 45% to 55% above the first half of the year levels.

主要收穫:由於11月份壓低了2022年上半年的收益,管理層引導2022年下半年調整後的EBITDA比上半年的水平高出45%至55%。

Mulvehill expects NOV to continue to benefit from rising oil field services capex, better pricing/fixed cost absorption and easing supply chains.

穆爾韋希爾預計,11月份將繼續受益於油田服務資本支出的上升、更好的定價/固定成本吸收以及供應鏈的放鬆。

NOV, formerly known as National Oilwell Varco, is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing.

Nov前身為National Oilwell Varco,是石油和天然氣鑽井設備和產品的領先供應商,如井下工具、鑽桿和油井套管。

See Also: How To Trade Nike Stock Before And After Q1 Earnings

參見:如何在第一季度收益之前和之後交易耐克股票

The company is set to become debt neutral by year-end 2023, and Mulvehill reported that he expects some of the least downside in consensus estimates among its peers should a recession occur.

該公司將在2023年底實現債務中性,穆爾韋希爾報告稱,他預計,如果發生經濟衰退,同行的普遍估計將出現一些最小的下行幅度。

For the fiscal year 2022, the B of A analysts forecasted EBITDA to be $640 million, up 1% from the consensus estimates, with earnings per share of 69 cents per share, up 28% from consensus estimates.

對於2022財年,美國銀行分析師預測EBITDA為6.4億美元,比普遍預期高出1%,每股收益為69美分,比普遍預期高出28%。

Mulvehill explained that with stronger pricing in new orders and higher volume allowing for better cost absorption, the analyst expects NOV's CAPS' segment to achieve EBITDA margin growth to high single digits by the year end and closer to the 2018 to 2019 peak of 14% over the subsequent 1-2 years, assuming no major recession.

穆爾韋希爾解釋説,隨着新訂單的更強勁定價和更高的銷量,從而能夠更好地吸收成本,分析師預計,假設沒有重大衰退,11月份的Caps部門到年底將實現EBITDA利潤率增長至較高的個位數,並在隨後的1-2年內更接近2018至2019年14%的峯值。

Additionally, NOV's Saudi rig manufacturing facility is ramping up and its offshore wind installation-related revenues are set to double to $400mm year-over-year.

此外,11月在沙特的鑽井平臺製造設施正在擴大,其海上風電安裝相關收入將同比翻一番,達到4億美元。

The Bull Case: Mulvehill reported if this cycle proves to have legs, it's not unlikely for NOV's total EBITDA margins to get to 15% eventually, which would imply potential EBITDA in the range of $1.2 billion to 1.4 billion.

牛市案例:穆爾韋希爾報告稱,如果這輪週期被證明是站得住腳的,那麼11月份的EBITDA總利潤率最終達到15%並不是不可能的,這意味着潛在的EBITDA在12億至14億美元之間。

With greater than 60% of NOV's 2023 forecasted revenues set to come from relatively more stable international markets, and net debt expected to fall to below zero by year-end 2023, NOV is more defensive when compared to its peers, Mulvehill mentioned.

穆爾韋希爾提到,由於11月2023年預測收入的60%以上將來自相對穩定的國際市場,預計到2023年底淨債務將降至零以下,與同行相比,11月更具防禦性。

See Also: Recession Signal? Softbank Vision Fund Weighs Downsizing Up To 30%

另見:衰退信號?軟銀願景基金權衡裁員至多30%

Therefore, if a recession is avoided, which would likely provide upside to our new estimates, we think its likely that NOV would revisit returning cash to shareholders in 2023, said Mulvehill.
The analyst's full-year EBITDA guidance for 2023 and 2024 is forecasted at $898 million and $1.1 billion, up 1% and 8% from consensus estimates, respectively. Earnings per share are expected to be 13% and 11% above consensus estimates.

因此,如果經濟衰退得以避免,我們認為11月可能會重新考慮在2023年向股東返還現金,這可能會給我們的新估計帶來好處,馬爾韋希爾表示。
該分析師對2023年和2024年全年EBITDA的指引預計分別為8.98億美元和11億美元,分別比普遍預期高出1%和8%。預計每股收益將分別比普遍預期高出13%和11%。

Competitor Buy Ratings: The analysts upgraded its price target on ChampionX (NASDAQ:CHX) to $22. The BofA analysts also issued Buy ratings for Schlumberger (NYSE:SLB) and Halliburton (NYSE:HAL)

競爭對手購買評級:分析師將其目標價上調至X錦標賽(納斯達克:CHX)至22美元。美國銀行的分析師還發布了買入評級斯倫貝謝(紐約證券交易所股票代碼:SLB)和哈里伯頓(紐約證券交易所代碼:HAL)

Photo By: Nestor Galina From Flickr

圖片來源:來自Flickr的Nestor Galina

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論